ENTB will have a huge move on the news of the possible merger with BMSN. Any way you look at it this is a positive development for the two companies to merge. If BMSN or ENTB get some acceptance of any of their developmental biomedical products both companies will surge. BMSN @ .0023 appears way undervalued. The last OS on ENTB I could find was July 2012 219M should move easy monday.
ENTEST BIOMEDICAL, INC.
(Exact name of small business issuer as specified in its charter)
Nevada 26-3431263
(State or other jurisdiction of incorporation
or organization)
(I.R.S. Employer Identification No.)
4700 Spring Street, St 304, La Mesa, California 91942
(Address of Principal Executive Offices)
619 702 1404
(Issuer’s telephone number)
None
(Former name, address and fiscal year, if changed since last report)
Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding
12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act.
[ ] Large accelerated filer [ ] Accelerated filer
[ ] Non-accelerated filer [X] Smaller reporting company
APPLICABLE ONLY TO CORPORATE ISSUERS:
As of July 12, 2012 there were 219,171,427 shares of common stock were issued and outstanding.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes [ ] No [X]
Transitional Small Business Disclosure Format (Check One) Yes [ ] No [X]
News 
Market Data 
Discover 
